Topics
Meningioma | Treatment | Targeted Therapy
Home > Publications > Topics > Meningioma > Treatment > Targeted Therapy
Limon D, Amiel A, Even Haim S, Gordon N, Tschernichovsky R,
Stemmer S, Gal O, Laviv Y, Kanner A, Siegal T, Yust-Katz S.
A
phase II, open-label, single-arm
trial of pembrolizumab for recurrent
meningioma and solitary fibrous tumor.
Neurooncol
Adv. 2024 Sep 16;6(1):vdae154. doi:
10.1093/noajnl/vdae154. PMID:
39429970. Interventional study. ˍ
Hajikarimloo B, Hasanzade A, Sabbagh Alvani M, Habibi MA.
Application of bevacizumab in the
management of meningiomas: a systematic review and meta-analysis.
Neurosurg
Rev. 2024 Sep 27;47(1):692. doi:
10.1007/s10143-024-02889-w. PMID:
39327340. Review˰ ˍ